Comments
State-owned LIC has cut its stake in Biocon to a little over 3 per cent by selling more than 2 per cent stake for over Rs 162 crore.
The country’s largest insurer offloaded 40,31,002 shares, constituting 2.01 per cent, for Rs 162.58 crore in Biocon through an open market transaction, the company said in a filing to the BSE.
LIC’s stake in Biocon has come down to 3.01 per cent from 5.02 per cent earlier after the offloading of shares, the biotechnology firm said.
Last month, LIC had announced that it had cut its stake in Ranbaxy Laboratories to a little over 6 per cent by selling more than two per cent stake over the past five years.
The company had offloaded 45,08,036 shares, constituting 2.01 per in Ranbaxy between October 15, 2008, and December 20, 2013.
LIC’s stake in Ranbaxy has come down to 6.13 per cent from 8.15 per cent during the period from October 15, 2008 and December 20, 2013.
Shares of Biocon were trading at Rs 451.70 on the BSE in late afternoon trade, up 2.31 per cent from their previous close.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.